BCL2 and breast carcinoma: This finding is consistent with our previous report showing increased breast cancer ER protein with aging without comparably increased levels of such estrogen-inducible markers as PR, pS2, Bcl2 and cathepsin D [13], and suggesting reduced estrogen signaling in breast tumors of older patients.